Neonates exposed to glucocorticoids in utero and carriers of the genetic variant NR3C1 rs6195 have poorer language and cognitive abilities (Van Der Voorn et al., 2015) and an increased risk of bronchopulmonary dysplasia (Haas et al., 2013). This evidence concerns the gene NR3C1 and bronchopulmonary dysplasia.